Edition:
India

Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

7.48USD
8 Dec 2016
Change (% chg)

$0.20 (+2.75%)
Prev Close
$7.28
Open
$7.22
Day's High
$7.50
Day's Low
$7.19
Volume
84,351
Avg. Vol
42,195
52-wk High
$7.50
52-wk Low
$4.00

ENZ.N

Chart for ENZ.N

About

Enzo Biochem, Inc. is a bioscience company focusing on delivering and applying technology capabilities to produce products and services. The Company's segments include Enzo Clinical Labs, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Labs is a clinical reference laboratory providing a range of clinical services to... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $346.17
Shares Outstanding(Mil.): 46.28
Dividend: --
Yield (%): --

Financials

BRIEF-S2G Biochem to collaborate with Mondelez for new sweetener process

* S2g Biochem announces collaboration with Mondelez International for new sweetener process

27 Oct 2016

BRIEF-Enzo Biochem announces New York State Health Department approval of new cardiac assay

* Enzo Biochem announces New York State Health Department approval of new easily adaptable, cost effective cardiac assay

20 Sep 2016

BRIEF-Enzo Biochem files for mixed shelf of up to $50 mln

* Files for mixed shelf of up to $50 million - SEC filing Source: (http://bit.ly/2cd7ICi) Further company coverage:

02 Sep 2016

Earnings vs. Estimates